New asthma drug tezspire tracked for Long-Term safety in Real-World use

NCT ID NCT05729711

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 34 times

Summary

This study follows 416 people with severe asthma that other treatments cannot control. Researchers are checking how safe and effective Tezspire is over long-term use, looking for side effects like serious infections or allergic reactions. The goal is to confirm the drug's safety in everyday medical practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Aichi, Japan
Research Site

Akita, Japan
Research Site

Aomori, Japan
Research Site

Chiba, Japan
Research Site

Fukui, Japan
Research Site

Fukuoka, Japan
Research Site

Gifu, Japan
Research Site

Gunma, Japan
Research Site

Hiroshima, Japan
Research Site

Hokkaido, Japan
Research Site

Hyōgo, Japan
Research Site

Ibaraki, Japan
Research Site

Ishikawa, Japan
Research Site

Kagawa, Japan
Research Site

Kanagawa, Japan
Research Site

Kumamoto, Japan
Research Site

Kyoto, Japan
Research Site

Mie, Japan
Research Site

Miyagi, Japan
Research Site

Nara, Japan
Research Site

Numakunai, Japan
Research Site

Okayama, Japan
Research Site

Osaka, Japan
Research Site

Ōita, Japan
Research Site

Saitama, Japan
Research Site

Shimane, Japan
Research Site

Shizuoka, Japan
Research Site

Tochigi, Japan
Research Site

Tokyo, Japan
Research Site

Toyama, Japan
Research Site

Wakayama, Japan
Research Site

Yamagata, Japan
Research Site

Yamaguchi, Japan
Research Site

Yamanashi, Japan

Conditions

Explore the condition pages connected to this study.

BRONCHIAL ASTHMA (ONLY THE PATIENTS WITH SEVERE OR INTRACTABLE BRONCHIAL ASTHMA WHICH COULD NOT BE CONTROLLED WITH THE EXISTING THERAPY)